Results 281 to 290 of about 67,365 (299)

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

Circulation, 2019
Thomas A Zelniker, Itamar Raz, Kyungah Im   +2 more
exaly  

Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis

Diabetes and Vascular Disease Research, 2016
Tracey Gaspari, Iresha Spizzo, Yunshan Hu   +2 more
exaly  

Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Provides Neuroprotection in Mice Transient Focal Cerebral Ischemia

Journal of Cerebral Blood Flow and Metabolism, 2011
Shinichiro Teramoto, Nobukazu Miyamoto, Kenji Yatomi   +2 more
exaly  

Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor

European Journal of Pharmacology, 1996
Lotte Bjerre Knudsen, Lone Pridal
exaly  

Cholelithiasis in patients treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice, 2020
Ilaria Dicembrini, Edoardo Mannucci, Matteo Monami   +2 more
exaly  

Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Events: Class Effects versus Individual Patterns

Trends in Endocrinology and Metabolism, 2018
Soo Lim, Michael A Nauck
exaly  

Glucagon-Like Peptide 1 Receptor: A Novel Pharmacological Target for Treating Human Bronchial Hyperresponsiveness

American Journal of Respiratory Cell and Molecular Biology, 2016
Paola Rogliani, Luigino Calzetta, Barbara Capuani   +2 more
exaly  

Decreased glucagon-like peptide 1 receptor expression in endothelial and smooth muscle cells in diabetic db/db mice: TCF7L2 is a possible regulator of the vascular glucagon-like peptide 1 receptor

Diabetes and Vascular Disease Research, 2017
Tomohiko Kimura, Atsushi Obata, Masashi Shimoda   +2 more
exaly  

Cardiovascular safety and glycemic control of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus: A pairwise and network meta-analysis

Diabetes Research and Clinical Practice, 2012
Feng Sun, Siyan Zhan
exaly  

Glucagon-Like Peptide-1 Receptor Agonists Increase Pancreatic Mass by Induction of Protein Synthesis

Diabetes, 2015
Jacqueline A Koehler, Laurie L Baggio, Xiemin Cao   +2 more
exaly